de Fost M - Search Results

1

Activation of cytotoxic lymphocytes in patients with scrub typhus.

de Fost M, Chierakul W, Pimda K, Dondorp AM, White NJ, Van der Poll T. de Fost M, et al. Am J Trop Med Hyg. 2005 Apr;72(4):465-7. Am J Trop Med Hyg. 2005. PMID: 15827287

2

Release of granzymes and chemokines in Thai patients with leptospirosis.

De Fost M, Chierakul W, Limpaiboon R, Dondorp A, White NJ, van Der Poll T. De Fost M, et al. Clin Microbiol Infect. 2007 Apr;13(4):433-6. doi: 10.1111/j.1469-0691.2006.01640.x. Clin Microbiol Infect. 2007. PMID: 17359329 Free article.

3

Differential expression of interferon-gamma and interferon-gamma-inducing cytokines in Thai patients with scrub typhus or leptospirosis.

Chierakul W, de Fost M, Suputtamongkol Y, Limpaiboon R, Dondorp A, White NJ, van der Poll T. Chierakul W, et al. Among authors: de fost m. Clin Immunol. 2004 Nov;113(2):140-4. doi: 10.1016/j.clim.2004.08.006. Clin Immunol. 2004. PMID: 15451469

4

Interleukin 12 in part regulates gamma interferon release in human whole blood stimulated with Leptospira interrogans.

de Fost M, Hartskeerl RA, Groenendijk MR, van der Poll T. de Fost M, et al. Clin Diagn Lab Immunol. 2003 Mar;10(2):332-5. doi: 10.1128/cdli.10.2.332-335.2003. Clin Diagn Lab Immunol. 2003. PMID: 12626464 Free PMC article.

5

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.

Boot RG, Verhoek M, de Fost M, Hollak CE, Maas M, Bleijlevens B, van Breemen MJ, van Meurs M, Boven LA, Laman JD, Moran MT, Cox TM, Aerts JM. Boot RG, et al. Among authors: de fost m. Blood. 2004 Jan 1;103(1):33-9. doi: 10.1182/blood-2003-05-1612. Epub 2003 Sep 11. Blood. 2004. PMID: 12969956 Free article.

6

Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease.

van Breemen MJ, de Fost M, Voerman JS, Laman JD, Boot RG, Maas M, Hollak CE, Aerts JM, Rezaee F. van Breemen MJ, et al. Among authors: de fost m. Biochim Biophys Acta. 2007 Jul;1772(7):788-96. doi: 10.1016/j.bbadis.2007.04.002. Epub 2007 Apr 14. Biochim Biophys Acta. 2007. PMID: 17499484 Free article.

7

Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.

de Fost M, Hollak CE, Groener JE, Aerts JM, Maas M, Poll LW, Wiersma MG, Häussinger D, Brett S, Brill N, vom Dahl S. de Fost M, et al. Blood. 2006 Aug 1;108(3):830-5. doi: 10.1182/blood-2005-12-5072. Epub 2006 Mar 9. Blood. 2006. PMID: 16527890 Free article.

8

Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial.

de Fost M, Aerts JM, Groener JE, Maas M, Akkerman EM, Wiersma MG, Hollak CE. de Fost M, et al. Haematologica. 2007 Feb;92(2):215-21. doi: 10.3324/haematol.10635. Haematologica. 2007. PMID: 17296571 Free article. Clinical Trial.

9

Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships.

Hollak CE, de Fost M, van Dussen L, Vom Dahl S, Aerts JM. Hollak CE, et al. Among authors: de fost m. Expert Opin Pharmacother. 2009 Nov;10(16):2641-52. doi: 10.1517/14656560903270520. Expert Opin Pharmacother. 2009. PMID: 19743939 Review.

10

Gaucher disease: from fundamental research to effective therapeutic interventions.

de Fost M, Aerts JM, Hollak CE. de Fost M, et al. Neth J Med. 2003 Jan;61(1):3-8. Neth J Med. 2003. PMID: 12688562 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters